FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso
Go back to FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso| Pfizer Inc. (NYSE: PFE) | Delayed: 28.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.24 | 52 Week High | $37.39 | |||
| Open | $28.24 | 52 Week Low | $28.25 | |||
| Day High | $28.24 | P/E | 17.12 | |||
| Day Low | $28.24 | EPS | $1.65 | |||
| Volume | 327,005 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.35 | 52 Week High | $1.11 | |||
| Open | $2.35 | 52 Week Low | $0.41 | |||
| Day High | $2.35 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $-0.29 | |||
| Volume | 20,510 | |||||
